Keywords: عامل رشد اپیدرمی انسان 2; BC; breast cancer; NAC; neoadjuvant chemotherapy; HER2; human epidermal growth factor 2; ER; oestrogen receptor; PR; progesterone receptor; TNBC; triple negative breast cancer; PET/CT; positron emission tomography computed tomography; pCR; pathologic comp
مقالات ISI عامل رشد اپیدرمی انسان 2 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عامل رشد اپیدرمی انسان 2; CAR; cortisol awakening response; EFA; exploratory factor analysis; ER; estrogen receptor; HER2/neu; human epidermal growth factor 2; HPA; hypothalamic-pituitary-adrenal; IES; Impact of Events Scale; IFN; interferon; IL; interleukin; MCP; monocyte che
Keywords: عامل رشد اپیدرمی انسان 2; S/B; signal to background; PDGFR; platelet-derived growth factor receptor; BTK; Bruton's tyrosine kinase; EGFR; epidermal growth factor receptor; HER-2; human epidermal growth factor 2; AMPK; AMP activated protein kinase; BMPR; bone morphogenetic protei
ESR1 single nucleotide polymorphism rs1062577 (c.*3804TÂ >Â A) alters the susceptibility of breast cancer risk in Iranian population
Keywords: عامل رشد اپیدرمی انسان 2; ATM; ataxia-telangiectasia mutated; BRCA1; BReast CAncer gene 1; BRCA2; BReast CAncer gene 2; CHECK2; checkpoint kinase 2; ER; estrogen receptor; ESR1; estrogen receptor 1; HER2; human epidermal growth factor 2; PR; progesterone receptor; PTEN; phosphatas
Molecular docking prediction and in vitro studies elucidate anti-cancer activity of phytoestrogens
Keywords: عامل رشد اپیدرمی انسان 2; ER; estrogen receptor; PR; progesterone receptor; HER2; human epidermal growth factor 2; ROS; reactive oxygen species; SARE; soybean aglycone rich extract; FSARE; flax seed aglycone rich extract; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium b
Prospective validation of a blood-based 9-miRNA profile for early detection of breast cancer in a cohort of women examined by clinical mammography
Keywords: عامل رشد اپیدرمی انسان 2; Breast cancer; Serum; Circulating miRNA profile; Biomarker; Early detection; ER; estrogen receptor; HER2; human epidermal growth factor 2; miRNA; microRNA; SOP; standard operational procedures; LNA; locked nucleic acid; AUC; area under the curve; ROC; rec
Toxicity of dual HER2-blockade with pertuzumab added to anthracycline versus non-anthracycline containing chemotherapy as neoadjuvant treatment in HER2-positive breast cancer: The TRAIN-2 study
Keywords: عامل رشد اپیدرمی انسان 2; Breast cancer; Toxicity; Human epidermal growth factor 2; Neoadjuvant treatment; Trastuzumab; Pertuzumab;
Intrinsic subtypes and genomic signatures of primary breast cancer and prognosis after systemic relapse
Keywords: عامل رشد اپیدرمی انسان 2; Intrinsic subtypes; Risk of recurrence score; Proliferation score; Gene expression signature; Metastatic breast cancer; IHC; immunohistochemistry; ER; estrogen receptor; PR; progesterone receptor; HER2; human epidermal growth factor 2; CISH; Chromogenic i
STAT signaling in different breast cancer sub-types
Keywords: عامل رشد اپیدرمی انسان 2; STAT; Signal Transducer and Activator of Transcription; ER; Estrogen Receptor; HER2; human epidermal growth factor 2; TNBC; Triple Negative Breast Cancer; IL; interleukin; PI3K; phosphatidylinositol 3-kinase; mTOR; mammalian target of rapamycin; JAK; Janu
HER2 aberrations in cancer: Implications for therapy
Keywords: عامل رشد اپیدرمی انسان 2; Human epidermal growth factor 2; Cancer; Target therapy; Trastuzumab; Lapatinib; Ado-trastuzumab emtansine; Pertuzumab; Afatinib;
Triple-Negative or HER2-Positive Status Predicts Higher Rates of Locoregional Recurrence in Node-Positive Breast Cancer Patients After Mastectomy
Keywords: عامل رشد اپیدرمی انسان 2; Breast neoplasm; Prognosis; Estrogen receptor; Progesterone receptor; Human epidermal growth factor 2;